Kenya launches long-acting injectable HIV prevention medicine in phased rollout

Kenya Receives First Doses of Long-Acting Injectable HIV Drug

Kenya has received its initial shipment of 21,000 starter doses of Lenacapavir, an injectable HIV pre-exposure prophylaxis (PrEP).

Kenya receives 21,000 doses of injectable HIV prevention drug

Kenya has received 21,000 starter doses of Lenacapavir, a long-acting injectable HIV prevention drug, positioning it as the first country in East Africa to introduce this innovation. This significant delivery marks a crucial step in the nation's fight against new HIV infections, particularly among its youth.

New HIV prevention injection arrives in Kenya

A new HIV prevention injection, Lenacapavir, has arrived in Kenya, offering a potentially "game-changing" treatment that requires only two injections a year.

Kenya receives 21,000 starter doses of injectable HIV prevention drug

Kenya's Ministry of Health has received its initial shipment of 21,000 starter doses of Lenacapavir, a twice-yearly injectable drug for HIV prevention, with rollout expected in early March.